Pediatric Ventricular Assist Devices - University of Minnesota ...

More documents

Recommendations

Info

% SurvivalSurvival to Transplant: Age at Listing100908070605040Age > 14 yrs(n=41)Age 10 -14 yrs(n=39)30Age < 10 yrs20(n=19)p=.00610Event: Death While Waiting*00 1 2 3 4 5 6 7 8 9 10 11 12Months after ImplantBlume et al. Circ 2006; PHTS 1993-2004
AGE DISTRIBUTION OF PEDIATRIC HEART RECIPIENTS(Transplants: January 1996 --June 2007)Number <strong>of</strong> Transplants1100100090080070060050040030020010000 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17Recipient Age (Years)ISHLT 2008J Heart Lung Transplant 2008;27: 937-983
Page 2 and 3: Disclosures• Berlin Heart Corpora
Page 4: Lillehei CW, Cohen M, Warden HE, et
Page 8 and 9: Pre 2004• ECMO• Adult Devices u
Page 10 and 11: ELSO Registry Survival by YearPedia
Page 12 and 13: Efficiency of ECMO as Bridge to Tra
Page 14 and 15: Survival in Children Bridged to Tra
Page 16 and 17: Post-Transplant Survival% Survival1
Page 18 and 19: Thoratec pVAD Ventricular AssistDev
Page 20 and 21: CHP Thoratec ExperiencePreimplantat
Page 24: Tx Wait Times (mo) by Era, Status,
Page 27 and 28: Berlin Heart EXCOR ® PediatricSyst
Page 29 and 30: Berlin Heart (EXCOR)
Page 31 and 32: MicroMedDebakeyPediatricVAD
Page 33 and 34: Conventional Centrifugal PumpFlüge
Page 35 and 36: Levitronix: A New GenerationCentriM
Page 37 and 38: Filling the GapGapWeeksShort-term U
Page 40 and 41: NHLBI PCSP: Contract DevicesPediaFl
Page 42 and 43: Design EvolutionHeartQuest42
Page 44 and 45: 180The PF3 Has Flatter HQ Curvestha
Page 46 and 47: Blood Interactions withCardiovascul
Page 48 and 49: VAD Biocompatibility Issues• Hemo
Page 50 and 51: Pre-clinical Ovine Model• Healthy
Page 52 and 53: Serum ChemistriesPF2.117 daysPF2.13
Page 54 and 55: Children’s Hospital of Pittsburgh

Pediatric Ventricular Assist Devices - University of Minnesota ...

Create successful ePaper yourself

Delete template?

Save as template?